Roche

Healthcare leaders share insights on successfully deploying screening and early disease detection technologies.

Laboratories increasingly face complex pressures potentially impacting results, operating costs, capacity, and turnaround times. By embracing digital solutions to create a more intelligent lab, organizations can be in full control – creating new value and unlocking new possibilities.

This webinar will share how healthcare organizations can enhance their digital infrastructure through best practices and lessons learned. It will address existing barriers to modernization, as well as the programs themselves. Additionally, it will illustrate how such effort can facilitate the scaling of digital technologies to improve screening and early disease detection, with the goal to improve patient outcomes and deliver more efficient, effective care.

How medical algorithms calculate risk to detect chronic disease early.

The current U.S. healthcare system may be strained by a growing workforce shortage, financial constraints and an aging Baby Boomer population, but screening and early disease detection programs offer much-needed support. They can help deliver more efficient and cost-effective treatment plans and better patient outcomes, thereby ensuring sustainability for healthcare providers. 

Ahmed Elhusseiny, Area Head, Asia Pacific at Roche Pharma shares his vision for how data-driven healthcare can transform patient outcomes in the region.

Corinne Dive-Reclus, global head of lab insights business at Roche Diagnostics, discusses the ways the company assists the healthcare industry by digitizing labs, accelerating access to innovation and giving providers actionable data.

Connecting data points is essential for improving the patient journey and ensuring patients receive continuous care, says Brian Pelkowski, Genentech's global head of oncology strategy for personalized healthcare.

With patient care virtualization in urgent need, Roche is supporting the sector using digital technology, says Darine Ghanem, the company's global head of personalized healthcare and patient access, global medical affairs.